The objective of this study was to determine the pattern of DUSP4 mRNA expression in locally advanced breast cancer patients pre- and post-neoadjuvant chemotherapy using anthracycline-based chemotherapy and the relationship with the clinical chemotherapeutic response. The gene discussed is DUSP4; the disease is breast cancer.